APO RESEARCH · REPORT
Blood Glucose Meters and Strips and Continuous Glucose Monitoring
While a blood glucose meter measures the amount of glucose through a drop of blood on a test strip, a CGM measures the amount of glucose in your interstitial fluid (the fluid surrounding your cells) through a sensor placed just under your skin.
Product & engineering
Understand the product.
While a blood glucose meter measures the amount of glucose through a drop of blood on a test strip, a CGM measures the amount of glucose in your interstitial fluid (the fluid surrounding your cells) through a sensor placed just under your skin.
Selected research
Market Analysis & Forecast
Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market Analysis and Forecast 2026-2032
Market perspective
While a blood glucose meter measures the amount of glucose through a drop of blood on a test strip, a CGM measures the amount of glucose in your interstitial fluid (the fluid surrounding your cells) through a sensor placed just under your skin.
The global Blood Glucose Meters and Strips and Continuous Glucose Monitoring market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Blood Glucose Meters and Strips and Continuous Glucose Monitoring is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Europe market for Blood Glucose Meters and Strips and Continuous Glucose Monitoring is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Asia-Pacific market for Blood Glucose Meters and Strips and Continuous Glucose Monitoring is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Blood Glucose Meters and Strips and Continuous Glucose Monitoring is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Blood Glucose Meters and Strips and Continuous Glucose Monitoring include Roche, LifeScan, Abbott Laboratories, Ascensia, ARKRAY, I-SENS, Omron, B. Braun and 77 Elektronika, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Blood Glucose Meters and Strips and Continuous Glucose Monitoring, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Blood Glucose Meters and Strips and Continuous Glucose Monitoring, also provides the revenue of main regions and countries. Of the upcoming market potential for Blood Glucose Meters and Strips and Continuous Glucose Monitoring, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Blood Glucose Meters and Strips and Continuous Glucose Monitoring revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Blood Glucose Meters and Strips and Continuous Glucose Monitoring market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Blood Glucose Meters and Strips and Continuous Glucose Monitoring revenue, projected growth trends, production technology, application and end-user industry.
Blood Glucose Meters and Strips and Continuous Glucose Monitoring Segment by Company
Roche
LifeScan
Abbott Laboratories
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
77 Elektronika
AgaMatrix
ALL Medicus
Terumo Corporation
Dexcom
Medtronic
Senseonics Holdings
Sinocare
Blood Glucose Meters and Strips and Continuous Glucose Monitoring Segment by Type
Blood Glucose Meters
Blood Glucose Strips
Continuous Glucose Monitoring (CGM) Systems
Blood Glucose Meters and Strips and Continuous Glucose Monitoring Segment by Application
Hospitals
Veterinary Station
Home Use
Pet Hospital
Blood Glucose Meters and Strips and Continuous Glucose Monitoring Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Glucose Meters and Strips and Continuous Glucose Monitoring market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Glucose Meters and Strips and Continuous Glucose Monitoring and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Glucose Meters and Strips and Continuous Glucose Monitoring.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Blood Glucose Meters and Strips and Continuous Glucose Monitoring in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Blood Glucose Meters and Strips and Continuous Glucose Monitoring company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Glucose Meters and Strips and Continuous Glucose Monitoring revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Blood Glucose Meters
- Blood Glucose Strips
- Continuous Glucose Monitoring (CGM) Systems
Applications
- Hospitals
- Veterinary Station
- Home Use
- Pet Hospital
Companies covered
- Roche
- LifeScan
- Abbott Laboratories
- Ascensia
- ARKRAY
- I-SENS
- Omron
- B. Braun
- 77 Elektronika
- AgaMatrix
- ALL Medicus
- Terumo Corporation
- Dexcom
- Medtronic
- Senseonics Holdings
- Sinocare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market by Type
- 1.2.1 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Blood Glucose Meters
- 1.2.3 Blood Glucose Strips
- 1.2.4 Continuous Glucose Monitoring (CGM) Systems
- 1.3 Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market by Application
- 1.3.1 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Veterinary Station
- 1.3.4 Home Use
- 1.3.5 Pet Hospital
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market Dynamics
- 2.1 Blood Glucose Meters and Strips and Continuous Glucose Monitoring Industry Trends
- 2.2 Blood Glucose Meters and Strips and Continuous Glucose Monitoring Industry Drivers
- 2.3 Blood Glucose Meters and Strips and Continuous Glucose Monitoring Industry Opportunities and Challenges
- 2.4 Blood Glucose Meters and Strips and Continuous Glucose Monitoring Industry Restraints
3 Global Growth Perspective
- 3.1 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market Perspective (2021-2032)
- 3.2 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Growth Trends by Region
- 3.2.1 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market Size by Region (2021-2026)
- 3.2.3 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Players
- 4.1.1 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Players (2021-2026)
- 4.1.2 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Key Players Headquarters & Area Served
- 4.4 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Players, Product Type & Application
- 4.5 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market CR5 and HHI
- 4.6.3 2025 Blood Glucose Meters and Strips and Continuous Glucose Monitoring Tier 1, Tier 2, and Tier 3
5 Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market Size by Type
- 5.1 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2021-2032)
- 5.3 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue Market Share by Type (2021-2032)
6 Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market Size by Application
- 6.1 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2021-2032)
- 6.3 Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Roche
- 7.1.1 Roche Company Information
- 7.1.2 Roche Business Overview
- 7.1.3 Roche Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.1.4 Roche Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.1.5 Roche Recent Developments
- 7.2 LifeScan
- 7.2.1 LifeScan Company Information
- 7.2.2 LifeScan Business Overview
- 7.2.3 LifeScan Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.2.4 LifeScan Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.2.5 LifeScan Recent Developments
- 7.3 Abbott Laboratories
- 7.3.1 Abbott Laboratories Company Information
- 7.3.2 Abbott Laboratories Business Overview
- 7.3.3 Abbott Laboratories Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.3.4 Abbott Laboratories Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.3.5 Abbott Laboratories Recent Developments
- 7.4 Ascensia
- 7.4.1 Ascensia Company Information
- 7.4.2 Ascensia Business Overview
- 7.4.3 Ascensia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.4.4 Ascensia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.4.5 Ascensia Recent Developments
- 7.5 ARKRAY
- 7.5.1 ARKRAY Company Information
- 7.5.2 ARKRAY Business Overview
- 7.5.3 ARKRAY Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.5.4 ARKRAY Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.5.5 ARKRAY Recent Developments
- 7.6 I-SENS
- 7.6.1 I-SENS Company Information
- 7.6.2 I-SENS Business Overview
- 7.6.3 I-SENS Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.6.4 I-SENS Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.6.5 I-SENS Recent Developments
- 7.7 Omron
- 7.7.1 Omron Company Information
- 7.7.2 Omron Business Overview
- 7.7.3 Omron Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.7.4 Omron Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.7.5 Omron Recent Developments
- 7.8 B. Braun
- 7.8.1 B. Braun Company Information
- 7.8.2 B. Braun Business Overview
- 7.8.3 B. Braun Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.8.4 B. Braun Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.8.5 B. Braun Recent Developments
- 7.9 77 Elektronika
- 7.9.1 77 Elektronika Company Information
- 7.9.2 77 Elektronika Business Overview
- 7.9.3 77 Elektronika Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.9.4 77 Elektronika Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.9.5 77 Elektronika Recent Developments
- 7.10 AgaMatrix
- 7.10.1 AgaMatrix Company Information
- 7.10.2 AgaMatrix Business Overview
- 7.10.3 AgaMatrix Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.10.4 AgaMatrix Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.10.5 AgaMatrix Recent Developments
- 7.11 ALL Medicus
- 7.11.1 ALL Medicus Company Information
- 7.11.2 ALL Medicus Business Overview
- 7.11.3 ALL Medicus Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.11.4 ALL Medicus Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.11.5 ALL Medicus Recent Developments
- 7.12 Terumo Corporation
- 7.12.1 Terumo Corporation Company Information
- 7.12.2 Terumo Corporation Business Overview
- 7.12.3 Terumo Corporation Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.12.4 Terumo Corporation Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.12.5 Terumo Corporation Recent Developments
- 7.13 Dexcom
- 7.13.1 Dexcom Company Information
- 7.13.2 Dexcom Business Overview
- 7.13.3 Dexcom Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.13.4 Dexcom Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.13.5 Dexcom Recent Developments
- 7.14 Medtronic
- 7.14.1 Medtronic Company Information
- 7.14.2 Medtronic Business Overview
- 7.14.3 Medtronic Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.14.4 Medtronic Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.14.5 Medtronic Recent Developments
- 7.15 Senseonics Holdings
- 7.15.1 Senseonics Holdings Company Information
- 7.15.2 Senseonics Holdings Business Overview
- 7.15.3 Senseonics Holdings Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.15.4 Senseonics Holdings Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.15.5 Senseonics Holdings Recent Developments
- 7.16 Sinocare
- 7.16.1 Sinocare Company Information
- 7.16.2 Sinocare Business Overview
- 7.16.3 Sinocare Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue and Gross Margin (2021-2026)
- 7.16.4 Sinocare Blood Glucose Meters and Strips and Continuous Glucose Monitoring Product Portfolio
- 7.16.5 Sinocare Recent Developments
8 North America
- 8.1 North America Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue (2021-2032)
- 8.2 North America Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2021-2032)
- 8.2.1 North America Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2021-2026)
- 8.2.2 North America Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2027-2032)
- 8.3 North America Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue Share by Type (2021-2032)
- 8.4 North America Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2021-2032)
- 8.4.1 North America Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2021-2026)
- 8.4.2 North America Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2027-2032)
- 8.5 North America Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue Share by Application (2021-2032)
- 8.6 North America Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country
- 8.6.1 North America Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country (2021-2026)
- 8.6.3 North America Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue (2021-2032)
- 9.2 Europe Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2021-2032)
- 9.2.1 Europe Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2021-2026)
- 9.2.2 Europe Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2027-2032)
- 9.3 Europe Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue Share by Type (2021-2032)
- 9.4 Europe Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2021-2032)
- 9.4.1 Europe Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2021-2026)
- 9.4.2 Europe Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2027-2032)
- 9.5 Europe Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue Share by Application (2021-2032)
- 9.6 Europe Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country
- 9.6.1 Europe Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country (2021-2026)
- 9.6.3 Europe Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue (2021-2032)
- 10.2 China Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2021-2032)
- 10.2.1 China Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2021-2026)
- 10.2.2 China Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2027-2032)
- 10.3 China Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue Share by Type (2021-2032)
- 10.4 China Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2021-2032)
- 10.4.1 China Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2021-2026)
- 10.4.2 China Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2027-2032)
- 10.5 China Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue (2021-2032)
- 11.2 Asia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2021-2032)
- 11.2.1 Asia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2021-2026)
- 11.2.2 Asia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2027-2032)
- 11.3 Asia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue Share by Type (2021-2032)
- 11.4 Asia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2021-2032)
- 11.4.1 Asia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2021-2026)
- 11.4.2 Asia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2027-2032)
- 11.5 Asia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue Share by Application (2021-2032)
- 11.6 Asia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country
- 11.6.1 Asia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country (2021-2026)
- 11.6.3 Asia Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue (2021-2032)
- 12.2 SAMEA Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2021-2032)
- 12.2.1 SAMEA Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2021-2026)
- 12.2.2 SAMEA Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Type (2027-2032)
- 12.3 SAMEA Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue Share by Type (2021-2032)
- 12.4 SAMEA Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2021-2032)
- 12.4.1 SAMEA Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2021-2026)
- 12.4.2 SAMEA Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Application (2027-2032)
- 12.5 SAMEA Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue Share by Application (2021-2032)
- 12.6 SAMEA Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country
- 12.6.1 SAMEA Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country (2021-2026)
- 12.6.3 SAMEA Blood Glucose Meters and Strips and Continuous Glucose Monitoring Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst